About this data
What it is
When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
Who files it
The insider, usually through the company, within two business days of the trade.
How current
We collect new filings throughout the day on SEC business days.
Worth knowing
Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.

All of this comes from public filings.

Open-market trades per day, last 30 days

05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0
05001,000Oct 17 · Purchases: 0Oct 17 · Sales: 0Oct 17Oct 18 · Purchases: 0Oct 18 · Sales: 0Oct 19 · Purchases: 29Oct 19 · Sales: 159Oct 20 · Purchases: 45Oct 20 · Sales: 209Oct 21 · Purchases: 38Oct 21 · Sales: 183Oct 21Oct 22 · Purchases: 50Oct 22 · Sales: 130Oct 23 · Purchases: 77Oct 23 · Sales: 126Oct 24 · Purchases: 1Oct 24 · Sales: 0Oct 25 · Purchases: 0Oct 25 · Sales: 0Oct 25Oct 26 · Purchases: 60Oct 26 · Sales: 171Oct 27 · Purchases: 27Oct 27 · Sales: 217Oct 28 · Purchases: 44Oct 28 · Sales: 135Oct 29 · Purchases: 35Oct 29 · Sales: 199Oct 29Oct 30 · Purchases: 68Oct 30 · Sales: 270Oct 31 · Purchases: 3Oct 31 · Sales: 0Nov 1 · Purchases: 2Nov 1 · Sales: 0Nov 2 · Purchases: 79Nov 2 · Sales: 826Nov 2Nov 3 · Purchases: 66Nov 3 · Sales: 337Nov 4 · Purchases: 67Nov 4 · Sales: 535Nov 5 · Purchases: 108Nov 5 · Sales: 458Nov 6 · Purchases: 137Nov 6 · Sales: 390Nov 6Nov 7 · Purchases: 0Nov 7 · Sales: 0Nov 8 · Purchases: 0Nov 8 · Sales: 0Nov 9 · Purchases: 110Nov 9 · Sales: 457Nov 10 · Purchases: 97Nov 10 · Sales: 406Nov 10Nov 11 · Purchases: 98Nov 11 · Sales: 330Nov 12 · Purchases: 54Nov 12 · Sales: 167Nov 13 · Purchases: 23Nov 13 · Sales: 28Nov 14 · Purchases: 0Nov 14 · Sales: 0Nov 14Nov 15 · Purchases: 0Nov 15 · Sales: 0

Purchases Sales

By trade date. Insiders have two business days to file, so the most recent days fill in later.

Latest open-market insider trades

Reset

Showing: ticker RCKT

Latest open-market insider trades
TradedInsiderCompanyTypeSharesPriceValueFiling
Nov 9, 2026Sarbani Chaudhuri
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale4,872$2.33$11.3K SaleForm 4 ↗
Nov 5, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale53,389$2.39$127.8K SaleForm 4 ↗
Sep 11, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale75,364$3.40$256.2K SaleForm 4 ↗
Aug 18, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale631$3.38$2,133 SaleForm 4 ↗
Aug 18, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale2,293$3.38$7,750 SaleForm 4 ↗
Aug 13, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale2,837$3.38$9,589 SaleForm 4 ↗
Aug 13, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale3,493$3.38$11.8K SaleForm 4 ↗
Aug 11, 2026Christopher James Stevens
Chief Operating Officer
RCKT
Rocket Pharmaceuticals, Inc.
Sale36,658$3.50$128.3K SaleForm 4 ↗
Aug 11, 2026Sarbani Chaudhuri
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale4,701$3.50$16.5K SaleForm 4 ↗
May 21, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale55,684$3.09$172.1K SaleForm 4 ↗
May 19, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale2,409$3.01$7,251 SaleForm 4 ↗
May 19, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale662$3.01$1,993 SaleForm 4 ↗
May 19, 2026John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale384$3.01$1,156 SaleForm 4 ↗
May 13, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale3,361$3.61$12.1K SaleForm 4 ↗
May 13, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale2,728$3.61$9,848 SaleForm 4 ↗
May 13, 2026John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale855$3.61$3,087 SaleForm 4 ↗
May 7, 2026Sarbani Chaudhuri
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale17,650$3.84$67.8K SaleForm 4 ↗
Feb 18, 2026John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,157$3.34$3,864 SaleForm 4 ↗
Feb 18, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale5,990$3.34$20.0K SaleForm 4 ↗
Feb 18, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,376$3.34$4,596 SaleForm 4 ↗
Feb 13, 2026Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale12,253$3.31$40.6K SaleForm 4 ↗
Feb 13, 2026John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale3,726$3.31$12.3K SaleForm 4 ↗
Feb 13, 2026Gaurav Shah
CEO
RCKT
Rocket Pharmaceuticals, Inc.
Sale12,279$3.31$40.6K SaleForm 4 ↗
Jan 2, 2026Elisabeth Bjork
Director
RCKT
Rocket Pharmaceuticals, Inc.
Buy10,000$3.44$34.4K BuyForm 4 ↗
Nov 18, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,086$2.98$3,236 SaleForm 4 ↗
Nov 18, 2025Jonathan David Schwartz
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale2,545$2.98$7,584 SaleForm 4 ↗
Nov 18, 2025Gaurav Shah
CEO, Director
RCKT
Rocket Pharmaceuticals, Inc.
Sale6,276$2.98$18.7K SaleForm 4 ↗
Nov 18, 2025Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,646$2.98$4,905 SaleForm 4 ↗
Oct 14, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale558$3.98$2,221 SaleForm 4 ↗
Oct 14, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale3,005$3.97$11.9K SaleForm 4 ↗
Oct 14, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale5,514$3.97$21.9K SaleForm 4 ↗
Oct 14, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale19,841$3.96$78.6K SaleForm 4 ↗
Aug 27, 2025Elisabeth Bjork
Director
RCKT
Rocket Pharmaceuticals, Inc.
Buy10,000$3.41$34.1K BuyForm 4 ↗
Aug 19, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale361$3.00$1,083 SaleForm 4 ↗
Aug 19, 2025Jonathan David Schwartz
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale805$3.00$2,415 SaleForm 4 ↗
Aug 19, 2025Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale588$3.00$1,764 SaleForm 4 ↗
Aug 18, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale699$3.07$2,146 SaleForm 4 ↗
Aug 18, 2025Jonathan David Schwartz
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,680$3.07$5,158 SaleForm 4 ↗
Aug 18, 2025Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,004$3.07$3,082 SaleForm 4 ↗
Aug 14, 2025Jonathan David Schwartz
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale11,161$3.02$33.7K SaleForm 4 ↗
Aug 14, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale7,043$3.02$21.3K SaleForm 4 ↗
Aug 14, 2025Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale12,109$3.02$36.6K SaleForm 4 ↗
Jul 3, 2025Aaron Ondrey
Chief Financial Officer
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,477$2.88$4,254 SaleForm 4 ↗
May 20, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale357$6.45$2,303 SaleForm 4 ↗
May 20, 2025Jonathan David Schwartz
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale801$6.45$5,166 SaleForm 4 ↗
May 20, 2025Kinnari Patel
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale767$6.45$4,947 SaleForm 4 ↗
May 20, 2025Gaurav Shah
CEO, Director
RCKT
Rocket Pharmaceuticals, Inc.
Sale2,253$6.45$14.5K SaleForm 4 ↗
May 20, 2025Martin Wilson
General Counsel
RCKT
Rocket Pharmaceuticals, Inc.
Sale587$6.45$3,786 SaleForm 4 ↗
May 16, 2025John Militello
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale655$6.53$4,277 SaleForm 4 ↗
May 16, 2025Kinnari Patel
See Remarks
RCKT
Rocket Pharmaceuticals, Inc.
Sale1,409$6.53$9,201 SaleForm 4 ↗

The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:50 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances